Christoph Nienaber | Cardiovascular Medicine | Excellence in Academia Award

Published on by Global Academic Awards

Excellence in Academia Award

Christoph Nienaber
Affiliation Royal Brompton and Harefield Hospitals
Country United Kingdom
Scholar ID pWDqkeQAAAAJ
Documents 1435
Citations 76,690
h-index 121
Subject Area Physical Activity
Event Global Academic Awards

Christoph Nienaber
Royal Brompton and Harefield Hospitals

Christoph Nienaber has established an internationally recognized academic profile through an extensive publication record, substantial citation impact, and continued contributions to cardiovascular medicine and clinical research. His scholarly influence is reflected through widely cited publications, interdisciplinary collaboration, and long-term engagement in evidence-based medical science.[1]

Abstract

Christoph Nienaber has developed an extensive academic career characterized by high-impact research, broad international collaboration, and significant scientific influence. Bibliometric indicators, including more than 1,400 indexed publications, over 76,000 citations, and an h-index exceeding one hundred, demonstrate sustained scholarly productivity and lasting academic impact. These indicators support recognition for long-term excellence in research and higher education.[1]

Keywords

  • Academic Excellence
  • Cardiovascular Medicine
  • Clinical Research
  • Evidence-Based Medicine
  • Scientific Leadership
  • Research Impact

Introduction

Academic excellence encompasses sustained scientific productivity, innovation, mentorship, and contributions that influence research, education, and clinical practice. Recognition through academic awards acknowledges individuals whose scholarly achievements have advanced knowledge within their respective disciplines and contributed to global scientific development.[2]

Research Profile

Christoph Nienaber is affiliated with Royal Brompton and Harefield Hospitals in the United Kingdom. His Google Scholar profile reports approximately 1,435 scholarly publications, over 76,690 citations, and an h-index of 121. These bibliometric measures illustrate exceptional academic productivity and a substantial influence on contemporary cardiovascular research.[1]

Research Contributions

  • Advancement of cardiovascular medicine and clinical cardiology.
  • Leadership in translational and evidence-based clinical research.
  • Extensive peer-reviewed scientific publications.
  • International collaboration and multidisciplinary research initiatives.
  • Contribution to clinical guidelines and medical education.

Publications

The researcher’s publication portfolio spans cardiovascular medicine, vascular diseases, clinical imaging, intervention, and translational healthcare research. Numerous articles have appeared in internationally recognized peer-reviewed journals and continue to receive substantial scholarly citations.[1]

Research Impact

High publication output combined with extensive citation performance demonstrates enduring scientific influence. The researcher’s work has contributed to clinical decision-making, medical education, and continued advancement of cardiovascular science through internationally recognized scholarly communication.[1]

Award Suitability

Based on publicly available bibliometric indicators and documented scholarly achievements, Christoph Nienaber demonstrates the characteristics commonly associated with recipients of academic excellence awards, including sustained publication productivity, exceptional citation impact, international scientific visibility, and long-term contributions to research and higher education. Final award determinations remain subject to independent evaluation by the awarding organization.[3]

Conclusion

Christoph Nienaber’s extensive scholarly record reflects sustained academic excellence, influential research, and meaningful contributions to cardiovascular medicine. His long-standing commitment to scientific inquiry, publication, and international collaboration illustrates the qualities recognized through the Excellence in Academia Award.

References

  1. Google Scholar. (n.d.). Author profile: Christoph Nienaber.
    https://scholar.google.com/citations?user=pWDqkeQAAAAJ&hl=en&oi=sra
  2. Aortic Diameter ≥5.5 cm Is Not a Good Predictor of Type A Aortic Dissection: Observations From the International Registry of Acute Aortic Dissection (IRAD).
    https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.107.702720
  3. Randomized Comparison of Strategies for Type B Aortic Dissection: The INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) Trial.
    https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.109.886408

 

Ankit Agrawal | Cardiology | Research Excellence Award

Published on by Global Academic Awards

Dr. Ankit Agrawal | Cardiology | Research Excellence Award

Dr. Ankit Agrawal is a cardiology fellow at the University of Arkansas for Medical Sciences with 943 citations, h-index 18, and 33 i10-index. His research spans structural cardiology, transcatheter valve therapies, pericardial diseases, cardiovascular imaging, meta-analyses, and outcomes research, emphasizing evidence-based strategies to improve cardiovascular care and patient safety.

Citation Metrics (Google Scholar)

1000

800

600

400

200

0

Citations 943

Documents 40+

h-index
18


View Google Scholar Profile

Featured Publications

Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

Published on by Global Academic Awards

Prof. Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

University of Bari Aldo Moro | Italy

Prof. Vincenzo Ezio Santobuono is an accomplished cardiologist and academic with a Classical High School Diploma (1999), a Degree in Medicine and Surgery from the University of Bari (2006, summa cum laude), a Specialization in Cardiology (2011, summa cum laude), and a PhD in Experimental and Forensic Medicine and Pathology (2015). He has built a distinguished career combining clinical expertise, academic leadership, and pioneering research in cardiology, particularly in telecardiology, remote monitoring, arrhythmia management, and cardiac resynchronization therapy. Professionally, he has served as Medical Director at the Regional TeleCardiology Center of Bari, specialist consultant for military and governmental institutions, and lecturer at the University of Bari “Aldo Moro” across nursing, medicine, radiology, psychiatric rehabilitation, and cardiovascular disease programs. Currently, he is a fixed-term researcher (RTD-A) leading an innovative project on telecardiology integration within hospital-territory networks. His academic impact is reflected in Scopus metrics with 502 citations, 52 indexed documents, and an h-index of 11, alongside numerous high-impact publications and a patent on supraventricular arrhythmia treatment. Fluent in English and Italian, he actively contributes to cardiovascular innovation, bridging advanced clinical practice with technological solutions to improve patient-centered care and healthcare delivery.

Profile: Scopus | Orcid

Featured Publications

  • Santobuono, V. E., et al. (2025). NPPA-associated atrial dilated cardiomyopathy: Genotypic and phenotypic insights from an ultrarare inherited disorder.

  • Santobuono, V. E., et al. (2025). Differentiating sensor changes in a composite heart failure ICD monitoring index: Clinical correlates and implications.

  • Santobuono, V. E., et al. (2025). Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis. International Journal of Cardiology.

  • Santobuono, V. E., et al. (2025). Kinetics of procalcitonin, CRP, IL-6, and presepsin in heart transplant patients undergoing induction with thymoglobulin (rATG). Journal of Clinical Medicine.

  • Santobuono, V. E., et al. (2025). Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators.

HASAN SARI | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Dr. HASAN SARI | Cardiology | Best Researcher Award

Dr. HASAN SARI, Mut State Hospital, Turkey

Dr. Hasan Sarı (b. 01.12.1991, Manavgat/Antalya) is a specialist in Cardiology. With several published works in leading journals, Dr. Sarı has contributed extensively to the fields of cardiac tumors, syncope, and aortic aneurysms. Notable publications include studies on malignant fibrous histiocytoma, right atrial thrombosis, and coronary ectasia. He has also presented at international conferences, including the ACC Middle East & Eastern Mediterranean 2023 in Athens. Dr. Sarı completed an observership at the University of Minnesota Medical Center in 2023. He is actively engaged in advancing cardiology research. 📚💉❤️📈

 

Publication Profile

Orcid

Research Focus

Dr. Hasan Sarı’s research primarily focuses on cardiology with a special interest in coronary artery diseases, cardiac arrhythmias, vascular pathology, and predictive models for cardiovascular conditions. His work includes evaluating the relationship between coronary ectasia and trimethylamine N-oxide, as well as exploring CHA2DS2-VASc scores and left ventricular apical thrombosis in heart failure patients. His research contributes to advancing cardiac diagnostics, understanding heart failure, and identifying biomarkers for cardiovascular health. Dr. Sarı’s publications are crucial for clinical practice and prevention strategies in cardiology. 🫀🔬💉📊

 

Publication Top Notes 📚

  • “The Evaluation of the Relationship Between Coronary Ectasia and Trimethylamine N‐Oxide” – International Journal of Clinical Practice (2024) 📅📝
  • “Kalp Yetmezlikli Hastalarda CHA2DS2-VASc Skoru ve Sol Ventrikül Apikal Trombozu İlişkisi” – Online Türk Sağlık Bilimleri Dergisi (2022) 📅📝

Xiangxiang Zheng | Cardiovascular Medicine | Best Researcher Award

Published on by Global Academic Awards

Dr. Xiangxiang Zheng | Cardiovascular Medicine | Best Researcher Award

Dr. Xiangxiang Zheng, Jiangsu Province Hospital, China

Dr. Xiangxiang Zheng, a dedicated cardiac surgeon at Jiangsu Provincial People’s Hospital since 2008, specializes in minimally invasive treatments for heart valve diseases and stem cell therapy for myocardial infarction. With a PhD and over 300 cardiac surgeries performed annually, he is at the forefront of cardiovascular innovation. His notable publications include research on engineering extracellular vesicles for diagnosis and therapy, and comparing surgical techniques for atrial septal defect repair. Dr. Zheng’s work significantly contributes to advancing surgical practices and improving patient outcomes. He is 42 years old and married. ❤️👨‍⚕️📚

 

Publication profile

Scopus


Professional Experience

Since 2008, Dr. Xiangxiang Zheng has been an esteemed cardiac surgeon in the Department of Cardiovascular Surgery at Jiangsu Provincial People’s Hospital. With over 300 cardiac surgeries performed annually, he has established himself as a leader in the field. Dr. Zheng specializes in minimally invasive treatments for heart valve diseases, which significantly reduce recovery time and improve patient outcomes. His expertise also extends to stem cell therapy for myocardial infarction, where he employs innovative techniques to enhance heart repair and regeneration. Dr. Zheng’s dedication to advancing cardiovascular care is evident through his hands-on surgical practice and commitment to exploring new methodologies in cardiac surgery. He continuously strives to improve surgical techniques and patient safety, making a lasting impact on the lives of those he treats. His contributions not only elevate the standard of care in his department but also serve as an inspiration to his colleagues and the medical community. 🌟👨‍⚕️📈

 

Research Focus

Dr. Xiangxiang Zheng’s research primarily focuses on cardiovascular surgery, particularly in innovative surgical techniques and therapies for heart diseases. His work emphasizes minimally invasive procedures, such as thoracoscopic surgeries for atrial septal defect repair, as well as advanced myocardial protection strategies during complex cardiac surgeries. Additionally, Dr. Zheng explores stem cell therapy and the engineering of extracellular vesicles for therapeutic applications, enhancing diagnosis and treatment methods in cardiology. His research also delves into the physiological impacts of surgical interventions on heart function and the progression of pulmonary arterial hypertension, contributing significantly to the field of cardiovascular medicine. 🏥📚✨

 

Publication Top Notes

  • Engineering extracellular vesicles for diagnosis and therapy 🧬
    Fei, Z., Zheng, J., Zheng, X., Ren, H., Liu, G.
    Trends in Pharmacological Sciences, 2024.
    Cited by: 0
  • The Impact of Highly Selective Thoracic Sympathectomy on the Progression of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats 🐭
    Liu, W., Men, C., Liu, Z., Zhang, L., Zheng, X.
    Journal of Physiological Investigation, 2024, 67(4), pp. 207-214.
    Cited by: 0
  • Triport Periareolar Thoracoscopic Surgery versus Right Minithoracotomy for Repairing Atrial Septal Defect in Adults 💔
    Zheng, X.-X., Wang, Z.-Y., Ma, L.-Y., Qin, J.-W., Shao, Y.-F.
    Interactive Cardiovascular and Thoracic Surgery, 2021, 32(2), pp. 313-318.
    Cited by: 5
  • Comparison of Myocardial Protection Effect between Del Nido Cardioplegia and Cold Blood Cardioplegia in Complex Cardiac Surgery 💉
    Jiao, S.-Y., Liu, L., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
    Chinese Journal of Clinical Research, 2020, 33(6), pp. 807-810.
    Cited by: 0
  • Myocardial Protective Effect of Three Cardioplegia in Adult Valve Replacement 💗
    Liu, H., Jiao, S.-Y., Ma, L.-Y., Zheng, X.-X., Qin, J.-W.
    Chinese Journal of Clinical Research, 2019, 32(6), pp. 775-778.
    Cited by: 1
  • Bilateral Superior Cervical Ganglionectomy Attenuates the Progression of β-Aminopropionitrile-induced Aortic Dissection in Rats 🧪
    Liu, H., Zheng, X., Zhang, L., Shao, Y., Zhang, S.
    Life Sciences, 2018, 193, pp. 200-206.
    Cited by: 5
  • Cardiac Autotransplantation for Repair of Left Ventricular Rupture after Mitral Valve Replacement 🏥
    Ni, B., Zheng, X., Zhang, S., Shao, Y.
    Interactive Cardiovascular and Thoracic Surgery, 2017, 25(1), pp. 150-152.
    Cited by: 3
  • Three Circulating LncRNA Predict Early Progress of Esophageal Squamous Cell Carcinoma 🔬
    Hu, H.-B., Jie, H.-Y., Zheng, X.-X.
    Cellular Physiology and Biochemistry, 2016, 40(1-2), pp. 117-125.
    Cited by: 68
  • High Expression of LncRNA PVT1 Promotes Invasion by Inducing Epithelial-to-Mesenchymal Transition in Esophageal Cancer 🚀
    Zheng, X., Hu, H., Li, S.
    Oncology Letters, 2016, 12(4), pp. 2357-2362.
    Cited by: 85
  • Myxoid Fibrosarcoma of the Left Atrium and Ventricle in Pregnancy 👶❤️
    Zhang, W., Zheng, X., Ni, B., Shao, Y., Zhang, S.
    Annals of Thoracic Surgery, 2014, 98(5), pp. 1818-1819.
    Cited by: 3